"You've probably heard of Ozempic, Wegovy, Zepbound, and Mounjaro. But if your algorithm serves up wellness and fitness content - like mine does - there's a good chance you've been seeing influencers talk about a new weight loss drug: retatrutide, the so-called GLP-3. The first video I saw was sent by a colleague. It features a fitness influencer enthusiastically saying "GLP-3, aka Ratatouille, as we have to call it here." In the upper right-hand corner is a disclaimer saying the video is for "educational" or "research" purposes only and to consult with a doctor."
"This particular creator says they've been using "ratatouille" for 102 days and lost 26 pounds. They talk about how "GLP-3s" contain semaglutide, gastric inhibitory polypeptide (GIP), and glucagon - hormones that help reduce appetite and burn fat. There's some truth in this, but it's definitely not that simple."
"If you search retatrutide on TikTok and Instagram, you'll find several influencers giving tips on dosing "reta," influencers asking followers to DM them or head to linktrees for "reputable" vendors complete with discount codes. Some are bodybuilders who claim they're simply into optimizing their bodies and looking for anything to give them an edge."
Retatrutide, labeled GLP-3, is appearing alongside drugs like Ozempic, Wegovy, Zepbound, and Mounjaro in online wellness conversations. Influencers on platforms such as TikTok and Instagram share personal anecdotes, dosing tips, and vendor links for retatrutide. Some creators display disclaimers but still encourage followers to DM or use linktrees for purchases and discount codes. Promoted benefits include appetite reduction and fat burning due to combined hormones like semaglutide, GIP, and glucagon. Some users report significant weight loss, while the biochemical effects and safety profile remain more complex than influencer claims suggest.
Read at The Verge
Unable to calculate read time
Collection
[
|
...
]